Correlation between ultrasound Tei index and cardiac injury in cancer patients after thoracic radiotherapy

摘要

Objective: To study the correlation between ultrasound Tei index and cardiac injury in cancer patients after thoracic radiotherapy. Methods: The 78 patients with malignant tumor who received thoracic radiotherapy in Mianyang Central Hospital, Sichuan, China between February 2015 and March 2018 were selected as observation group, and 60 healthy volunteers who underwent physical examination during the same period were selected as control group. The observation group underwent cardiac ultrasonography before and after radiotherapy to calculate Tei indexes and serum was collected to determine cardiac injury markers, inflammatory cytokines and oxidative stress mediators, while the control group underwent cardiac ultrasonography during the physical examination to calculate Tei indexes and serum was collected to determine cardiac injury markers, inflammatory cytokines and oxidative stress mediators.Results: Left cardiac Tei index, right cardiac Tei index as well as serum creatine phosphokinase, creatine phosphokinase isoenzyme, troponin I, interferon-induced protein-10, interleukin-6, interleukin-10, transforming growth factor-β1 and 8-hydroxy-2-deoxyguanosine contents of the observation group after radiotherapy were significantly higher than those before radiotherapy and those of the control group (P<0.05), while serum total antioxidant capacity, superoxide dismutase and glutathione peroxidase contents were significantly lower than those before radiotherapy and those of the control group (P<0.05); Tei indexes were positively correlated with serum creatine phosphokinase, creatine phosphokinase isoenzyme, troponin I, interferon-induced protein-10, interleukin-6, interleukin-10, transforming growth factor-β1 and 8-hydroxy-2-deoxyguanosine contents, and negatively correlated with serum total antioxidant capacity, superoxide dismutase and glutathione peroxidase contents. Conclusions:Ultrasound Tei index is valuable in evaluating the cardiac injury in cancer patients after thoracic radiotherapy.